Citadel Advisors »

CanFite Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of CanFite Biopharma (CANF) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in CanFite Biopharma

Tip: Access up to 7 years of quarterly data

All positions including CanFite Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CanFite Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $106k 34k 3.10

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding CanFite Biopharma

Citadel Advisors
Rhumbline Advisers
Hrt Financial
Citigroup
UBS Group
Fifth Third Bancorp
Wells Fargo & Company
Activest Wealth Management
Efficient Wealth Management
Morgan Stanley
TD Waterhouse Canada

View all funds holding CanFite Biopharma